Determining the extent of heparan sulfate depolymerisation following heparin lyase treatment.

[1]  A. V. van Wijnen,et al.  Affinity Selection of FGF2‐Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells , 2017, Journal of cellular physiology.

[2]  R. Linhardt,et al.  Abnormally High Content of Free Glucosamine Residues Identified in a Preparation of Commercially Available Porcine Intestinal Heparan Sulfate , 2016, Analytical chemistry.

[3]  Chuay-Yeng Koo,et al.  Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy. , 2014, Biomaterials.

[4]  J. Esko,et al.  Demystifying heparan sulfate-protein interactions. , 2014, Annual review of biochemistry.

[5]  H. Wong,et al.  Affinity-selected heparan sulfate for bone repair. , 2013, Biomaterials.

[6]  F. Galeotti,et al.  Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides. , 2013, Journal of chromatography. A.

[7]  J. Turnbull,et al.  Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection , 2010, Nature Protocols.

[8]  J. Meissen,et al.  Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides. , 2009, Analytical chemistry.

[9]  M. Lyon,et al.  A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. , 2008, Glycobiology.

[10]  J. Turnbull,et al.  High sensitivity separation and detection of heparan sulfate disaccharides. , 2006, Journal of chromatography. A.

[11]  M. Pardue,et al.  The Journal of Cell Biology , 2002 .

[12]  Joseph Zaia,et al.  Size-exclusion chromatography of heparin oligosaccharides at high and low pressure. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Renato V Iozzo,et al.  Heparan sulfate: a complex polymer charged with biological activity. , 2005, Chemical reviews.

[14]  M. Lyon,et al.  Distinct Substrate Specificities of Bacterial Heparinases against N-Unsubstituted Glucosamine Residues in Heparan Sulfate* , 2005, Journal of Biological Chemistry.

[15]  R. Langer,et al.  Rational design of low-molecular weight heparins with improved in vivo activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Rabenstein.  Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.

[17]  G. Giménez-Gallego,et al.  Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.

[18]  R. Linhardt,et al.  Analysis of glycosaminoglycans with polysaccharide lyases. , 2001, Current protocols in molecular biology.

[19]  J. Turnbull,et al.  Structural Modification of Fibroblast Growth Factor-binding Heparan Sulfate at a Determinative Stage of Neural Development* , 1998, The Journal of Biological Chemistry.

[20]  N. Karamanos,et al.  Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. , 1997, Journal of chromatography. A.

[21]  P. N. Shaklee,et al.  Absolute molecular weight distribution of low-molecular-weight heparins by size-exclusion chromatography with multiangle laser light scattering detection. , 1997, Analytical biochemistry.

[22]  R. Linhardt,et al.  Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin. , 1995, Carbohydrate research.

[23]  K. Yoshida,et al.  High-performance liquid chromatographic identification of eight constitutional disaccharides from heparan sulfate isomers digested with heparitinases. , 1995, Journal of chromatography. B, Biomedical applications.

[24]  M. Lyon,et al.  Liver heparan sulfate structure. A novel molecular design. , 1994, The Journal of biological chemistry.

[25]  R. U. Margolis,et al.  Disaccharide Composition of Heparan Sulfates: Brain, Nervous Tissue Storage Organelles, Kidney, and Lung , 1994, Journal of neurochemistry.

[26]  K. Khoo,et al.  Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin. , 1993, The Journal of biological chemistry.

[27]  C. Larive,et al.  Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate , 2009, Analytical and bioanalytical chemistry.

[28]  S. Bertini,et al.  Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array. , 2005, Biomacromolecules.

[29]  R. Linhardt,et al.  Degradation of heparan sulfate with heparin lyases. , 2001, Methods in molecular biology.

[30]  A. Hjerpe,et al.  High performance capillary electrophoresis method to characterize heparin and heparan sulfate disaccharides , 1996, Electrophoresis.